  erry
J. Conrad, President and Chief Executive Officer of
Merz Pharmaceuticals LLC, is a 16-year veteran of the pharmaceutical
industry. He was most recently Senior Director of Business Development
at the Parke-Davis division of Warner Lambert. In that position,
he was responsible for leading all business development projects
for the US pharmaceuticals division. Prior to his work with
Warner Lambert, he also worked for Bayer AG in Germany for several
years, where he was responsible for the global marketing strategy
and business development efforts within the cardiovascular product
development group.
From 1987 through 1995, Conrad held various marketing, sales,
and business management positions in a variety of specialty
areas within the domestic and international divisions of Lederle
Laboratories, a division of American Cyanamid. During his time
at American Cyanamid, he also served on the board of directors
for the firm’s credit union as well as on a product alliance
advisory board with Takeda Laboratories of Japan.
Conrad came to Merz Pharmaceuticals as president and CEO in
September 2000 and holds a BS in Chemistry from St. John’s
University in Minnesota, and a Master’s in Social and Administrative
Pharmacy from the University of Minnesota.
^ Top
 Kevin M. Barth, Vice President
of Sales for Merz Pharmaceuticals, LLC, joined Merz in 2001.
Barth comes to Merz from the Parke-Davis division of Pfizer
and brings with him over 17 years of sales, sales training,
and sales leadership experience. He began his pharmaceutical
career with Marion Laboratories and continued to advance through
the series of mergers that evolved into Hoechst Marion Roussel
(now Aventis).
Barth has worked in many areas within the pharmaceutical industry,
including Internal Medicine, Cardiology, Gastroenterology, Oncology,
Nephrology, and Endocrinology. Prior to entering the pharmaceutical
industry, he gained operations experience as a Senior Operations
Manager in the retail industry.
Barth holds a BS from Southern Illinois University and an MA
in International Business from Webster University.
^ Top
 Robert W. Burgess,
Vice President of Finance and Administration for Merz
Pharmaceuticals, LLC, has been with Merz and its predecessor,
Mayrand Pharmaceuticals, for 12 years. Burgess joined the company
as Secretary/Treasurer in 1991 and worked with Goody’s
Pharmaceuticals, Mayrand’s parent company, in a joint
capacity from 1992 to 1995. Prior to working for Mayrand, Burgess
held positions as General Staff, Senior Staff, Manager, and
Senior Manager with McGladrey & Pullen, a national public
accounting firm.
Burgess is also a member of the Executive Committee of Merz
Pharmaceuticals, LLC and serves as Vice President of Finance
and Administration for Merz, Inc., the parent/holding company
of Merz Pharmaceuticals, LLC.
Burgess holds a BS/BA with a concentration in accounting from
the University of North Carolina at Chapel Hill. He obtained
his CPA certification in 1984 and is a member of the American
Institute of Certified Public Accountants and the North Carolina
Association of Certified Public Accountants.
^ Top
 Bhushan Hardas, MD, MBA,
Vice President of US Research & Development joined Merz Pharmaceuticals, LLC
in 2004 to oversee all medical, regulatory and quality functions. Prior to joining Merz, Dr.
Hardas was director of dermatology at Procyon Biopharma, Inc., a Montreal-based Canadian biotechnology
company, where he led the scientific, medical and clinical activities supporting all aspects
of the company's dermatology business. Earlier, Dr. Hardas also spent eight years at Derm Cosmetic
Labs, advancing to the position of research and development executive director.
Dr. Hardas received advanced training in clinical immunology and molecular biology at King's College
London at the University of London, in London, England. He also completed a research fellowship in the
Department of Dermatology at the University of Michigan, and received his MBA in healthcare management
from the University of California - Irvine.
His work in skin biology has been published in the Journal of Investigative Dermatology and
the Journal of Dermatology, and he has been recognized by the Dermatology Foundation, the
Veteran's Administration and the National Institute of Health.
Dr. Hardas's professional affiliations include memberships in American Academy of Dermatology,
Wound Healing Society, and the U.S.-based Regulatory Affairs Professional Society. He is a patron
member of Society for Investigational Dermatology, a member of leaders society at Dermatology Foundation,
as well as the Molecular Biology Cancer Network, and Royal Society of Medicine based in the United Kingdom.
^ Top
 Mary Ann Hauser, Director
of Marketing for Merz Pharmaceuticals, LLC, joined Merz in 1999
as a Product Manager and has since been promoted to Group Product
Manager and, most recently, Director of Marketing, overseeing
the marketing of all Merz’ product lines.
Prior to joining Merz, Hauser was Group Product Manager for
Bradley Pharmaceuticals. She began her career with Olin Corporation,
where she spent 14 years in various sales and marketing positions,
including National Account Manager in the specialty chemical
group, Marketing Manager for Olin’s private label division,
and Product Manager for their OEM (original equipment manufacturer)
division.
^ Top
 Mark Stauffer, Director
of Contract Manufacturing, Materials Management and Logistics
for Merz Pharmaceuticals, LLC, brings to Merz over 20 years
of manufacturing and materials management leadership experience.
He began his manufacturing career in 1981 with Estee Lauder
in metropolitan New York and comes to Merz after 13 years with
ConvaTec, a division of Bristol Myers Squibb, where he was most
recently the Director of Supply Chain, responsible for purchasing,
planning, warehouse operations, and export market services.
Stauffer graduated from Syracuse University with a BS in Business
Administration. He is a member of the American Production &
Inventory Control Society and Council of Logistics and also
sits on the Board of Directors for the Greensboro Chapter of
the American Red Cross.
^ Top
|
